Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Oncologic Impact of Renal Tissue Adjacent to Renal Cell Carcinoma

STEFAN AUFDERKLAMM, JÖRG HENNENLOTTER, TILMAN TODENHÖFER, NICOLAS SENGHAAS, MARCUS SCHARPF, GEORGIOS GAKIS, STEFFEN RAUSCH, JOHANNES MISCHINGER, SIMONE BIER, ARNULF STENZL, CHRISTIAN SCHWENTNER and JENS BEDKE
Anticancer Research June 2016, 36 (6) 2865-2869;
STEFAN AUFDERKLAMM
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JÖRG HENNENLOTTER
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TILMAN TODENHÖFER
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NICOLAS SENGHAAS
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARCUS SCHARPF
2Department of Pathology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGIOS GAKIS
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFFEN RAUSCH
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHANNES MISCHINGER
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMONE BIER
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARNULF STENZL
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTIAN SCHWENTNER
3Department of Urology, Diakonie Klinikum Stuttgart, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JENS BEDKE
1Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jens.bedke{at}med.uni-tuebingen.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: The aim of the study was to investigate the clinical impact of the surgical margin width after nephron-sparing surgery (NSS) on the oncological course of renal cell carcinoma (RCC). Patients and Methods: The study comprised of 126 RCC patients with NSS between 2002 and 2009. Inclusion criteria were negative resection margins and a tumor diameter of ≤100 mm with the possibility of a complete circumferential histopathological reevaluation. The minimal benign margin width was correlated to the patients' clinical course. Results: Median safety margin width was revealed to be 1 mm. Nine of 126 patients (7.1%) developed recurrent disease (five local, four distant). All patients with local recurrence had safety margins ≤1 mm, whereas out of 49 patients with a margin >1 mm no one developed local recurrence (p=0.0245). Safety margin ≤1 mm showed associations with increased risk for overall recurrence in univariate and multivariate analysis (p=0.0531 and 0.0539, respectively). Conclusion: Tumor adjacent renal parenchyma may have oncological relevance, corroborating the need for further molecular investigation of tumor-adjacent tissue in RCC.

  • Renal cell carcinoma
  • nephron-sparing surgery
  • parenchyma
  • safety margin
  • recurrence
  • oncological outcome
  • Received April 3, 2016.
  • Revision received May 9, 2016.
  • Accepted May 17, 2016.
  • Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 36, Issue 6
June 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Oncologic Impact of Renal Tissue Adjacent to Renal Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Oncologic Impact of Renal Tissue Adjacent to Renal Cell Carcinoma
STEFAN AUFDERKLAMM, JÖRG HENNENLOTTER, TILMAN TODENHÖFER, NICOLAS SENGHAAS, MARCUS SCHARPF, GEORGIOS GAKIS, STEFFEN RAUSCH, JOHANNES MISCHINGER, SIMONE BIER, ARNULF STENZL, CHRISTIAN SCHWENTNER, JENS BEDKE
Anticancer Research Jun 2016, 36 (6) 2865-2869;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Oncologic Impact of Renal Tissue Adjacent to Renal Cell Carcinoma
STEFAN AUFDERKLAMM, JÖRG HENNENLOTTER, TILMAN TODENHÖFER, NICOLAS SENGHAAS, MARCUS SCHARPF, GEORGIOS GAKIS, STEFFEN RAUSCH, JOHANNES MISCHINGER, SIMONE BIER, ARNULF STENZL, CHRISTIAN SCHWENTNER, JENS BEDKE
Anticancer Research Jun 2016, 36 (6) 2865-2869;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma
  • Google Scholar

More in this TOC Section

  • Over-expression of Anillin Actin Binding Protein in Adrenocortical Carcinoma Tissues Is Associated With Poorer Prognosis of Patients
  • Clinicopathological Significance of HER2 Expression Redefined by the HER2-low Concept in Ductal Carcinoma In Situ
  • Radiotherapy Strategies for Stage II Breast Cancer With Lymphovascular Invasion After Mastectomy
Show more Clinical Studies

Keywords

  • Renal cell carcinoma
  • nephron-sparing surgery
  • parenchyma
  • safety margin
  • recurrence
  • oncological outcome
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire